EKSO:NASDAQ
Ekso Bionics Holdings Inc
US$ 11,78
arrow_downward
-1,92%(-0,23) 1D
1 de mai., 11:36:48 GMT-4 · USD
search
Todos os símbolos
1D
5D
1M
6M
YTD
1A
5A
MÁX
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para EKSO…
Abrir
US$ 12,26
Alta
US$ 12,31
Baixa
US$ 11,74
Valor de mercado
43,58 mi
Volume médio
73,11 mil
Volume
7,23 mil
Alto — 52 sem
US$ 13,50
Baixo — 52 sem
US$ 2,73
LPA
-US$ 4,91
Beta
0,78
Ações em circulação
3,56 mi
Nº de funcionários
50
Notícias
De fontes em toda a Web
Perfil
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Sobre Ekso Bionics Holdings Inc
CEOScott Davis
Funcionários50
Data de fundação2005
SedeSão Rafael, Califórnia, Estados Unidos
Setor-
Siteeksobionics.com
O conteúdo gerado com IA pode ter erros. Saiba mais